ATE302770T1 - Benzimidazolverbindungen die nociceptinrezeptoraffinität haben - Google Patents

Benzimidazolverbindungen die nociceptinrezeptoraffinität haben

Info

Publication number
ATE302770T1
ATE302770T1 AT00980981T AT00980981T ATE302770T1 AT E302770 T1 ATE302770 T1 AT E302770T1 AT 00980981 T AT00980981 T AT 00980981T AT 00980981 T AT00980981 T AT 00980981T AT E302770 T1 ATE302770 T1 AT E302770T1
Authority
AT
Austria
Prior art keywords
nociceptine
receptor affinity
benzimidazole compounds
compounds
affinity
Prior art date
Application number
AT00980981T
Other languages
English (en)
Inventor
Donald Kyle
Richard R Goehring
Bin Shao
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of ATE302770T1 publication Critical patent/ATE302770T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00980981T 1999-12-06 2000-12-06 Benzimidazolverbindungen die nociceptinrezeptoraffinität haben ATE302770T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16939499P 1999-12-06 1999-12-06
PCT/US2000/033019 WO2001039775A1 (en) 1999-12-06 2000-12-06 Benzimidazole compounds having nociceptin receptor affinity

Publications (1)

Publication Number Publication Date
ATE302770T1 true ATE302770T1 (de) 2005-09-15

Family

ID=22615490

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00980981T ATE302770T1 (de) 1999-12-06 2000-12-06 Benzimidazolverbindungen die nociceptinrezeptoraffinität haben

Country Status (8)

Country Link
US (2) US7456198B2 (de)
EP (1) EP1242085B1 (de)
JP (2) JP2003524634A (de)
AT (1) ATE302770T1 (de)
AU (1) AU1816901A (de)
DE (1) DE60022226D1 (de)
HK (1) HK1049284B (de)
WO (1) WO2001039775A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1816901A (en) * 1999-12-06 2001-06-12 Euro-Celtique S.A. Benzimidazole compounds having nociceptin receptor affinity
IL158484A0 (en) * 2001-04-18 2004-05-12 Euro Celtique Sa Nociceptin analogs
CA2465328C (en) * 2001-11-01 2011-06-14 Michael Francis Gross Piperidines
JP4056977B2 (ja) 2002-03-29 2008-03-05 田辺三菱製薬株式会社 睡眠障害治療薬
JP2005289816A (ja) * 2002-05-14 2005-10-20 Banyu Pharmaceut Co Ltd ベンズイミダゾール誘導体
DE10252666A1 (de) * 2002-11-11 2004-08-05 Grünenthal GmbH N-Piperidyl-cyclohexan-Derivate
US7202259B2 (en) * 2002-11-18 2007-04-10 Euro-Celtique S.A. Therapeutic agents useful for treating pain
AR045939A1 (es) 2003-09-25 2005-11-16 Solvay Pharm Bv Derivados de bencimidazolona y quinazolinona como agonistas de los receptores orl 1 humanos
AR045843A1 (es) 2003-10-03 2005-11-16 Solvay Pharm Bv Derivados de bencimidazolonas y quinazolinonas sustituidas con hidronopol como agonistas en receptores orl 1 humanos
KR100886002B1 (ko) 2004-01-30 2009-03-03 유로-셀띠끄 소시에떼 아노님 4-테트라졸릴-4-페닐피페리딘 화합물의 제조방법
UA83919C2 (en) * 2004-04-20 2008-08-26 Санофи Авентис Polymorphic forms of methyl(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4h) acetate hydrobromide, clopidrogel hydrobromide
US7300947B2 (en) * 2005-07-13 2007-11-27 Banyu Pharmaceutical Co., Ltd. N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives
AR054816A1 (es) * 2005-07-13 2007-07-18 Banyu Pharma Co Ltd Derivados de n-dihidroxialquil 2-oxo- imidazol sustituidos
WO2007037513A1 (ja) * 2005-09-30 2007-04-05 Banyu Pharmaceutical Co., Ltd. アリール置換含窒素複素環化合物
US20080015214A1 (en) * 2005-10-24 2008-01-17 Bignan Gilles C 3-piperidin-4-yl-indole orl-1 receptor modulators
JP2009525269A (ja) * 2006-01-30 2009-07-09 ユーロ−セルティーク エス.エイ. カルシウムチャネルブロッカーとしての環状尿素化合物
GB0605784D0 (en) * 2006-03-22 2006-05-03 Glaxo Group Ltd Compounds
GB0605786D0 (en) * 2006-03-22 2006-05-03 Glaxo Group Ltd Compounds
US8775704B2 (en) * 2006-04-05 2014-07-08 Nvidia Corporation Method and system for communication between a secondary processor and an auxiliary display subsystem of a notebook
DE102006046745A1 (de) * 2006-09-29 2008-04-03 Grünenthal GmbH Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz
EP2397477B1 (de) * 2007-01-16 2014-03-05 Purdue Pharma LP Heterocyclisch-substituierte Piperidinverbindungen und Verwendungen davon
BRPI0808025A2 (pt) * 2007-03-01 2014-06-24 Mitsubishi Tanabe Pharma Corp Composto de benzimidazol e uso farmacêutico do mesmo
RU2451017C2 (ru) * 2007-03-01 2012-05-20 Мицубиси Танабе Фарма Корпорейшн Бензимидазольное соединение и его фармацевтическое применение
MY150602A (en) 2007-08-31 2014-01-30 Purdue Pharma Lp Subtituted-quinoxaline-type piperidine compounds and the uses thereof
WO2009124883A1 (en) * 2008-04-09 2009-10-15 H. Lundbeck A/S Novel 1,3-dihydro-benzoimidazol-2-ones as m1 agonists
KR101333660B1 (ko) 2008-07-21 2013-11-27 시오노기세이야쿠가부시키가이샤 치환-퀴녹살린-형 가교-피페리딘 화합물 및 그의 용도
US8736617B2 (en) * 2008-08-04 2014-05-27 Nvidia Corporation Hybrid graphic display
TW201016675A (en) 2008-09-16 2010-05-01 Mitsubishi Tanabe Pharma Corp Crystalline benzoimidazole compound and salt thereof
US9075559B2 (en) * 2009-02-27 2015-07-07 Nvidia Corporation Multiple graphics processing unit system and method
US9135675B2 (en) * 2009-06-15 2015-09-15 Nvidia Corporation Multiple graphics processing unit display synchronization system and method
US8766989B2 (en) * 2009-07-29 2014-07-01 Nvidia Corporation Method and system for dynamically adding and removing display modes coordinated across multiple graphics processing units
US8780122B2 (en) * 2009-09-16 2014-07-15 Nvidia Corporation Techniques for transferring graphics data from system memory to a discrete GPU
US9111325B2 (en) * 2009-12-31 2015-08-18 Nvidia Corporation Shared buffer techniques for heterogeneous hybrid graphics
US9951038B2 (en) 2012-12-27 2018-04-24 Purdue Pharma L.P. Quinazolin-4(3H)-one-type piperidine compounds and uses thereof
US10118927B2 (en) 2012-12-27 2018-11-06 Purdue Pharma L.P. Substituted piperidin-4-amino-type compounds and uses thereof
WO2014102594A2 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Substituted benzimidazole-type piperidine compounds and uses thereof
WO2014102588A2 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Indole and indoline-type piperidine compounds and uses thereof
US9818379B2 (en) 2013-08-08 2017-11-14 Nvidia Corporation Pixel data transmission over multiple pixel interfaces
US20240287019A1 (en) * 2021-06-07 2024-08-29 Kinki University T-type calcium channel blocker
CN121843930A (zh) * 2024-01-05 2026-04-10 宜昌人福药业有限责任公司 一种环己基取代哌啶衍生物、包含其的药物组合物及其用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE633495A (de) * 1962-06-13
US3161645A (en) 1962-12-18 1964-12-15 Res Lab Dr C Janssen N V 1-(1-aroylpropyl-4-piperidyl)-2-benzimidazolinones and related compounds
US3318900A (en) 1964-05-06 1967-05-09 Janssen Pharmaceutica Nv Derivatives of benzimidazolinyl piperidine
GR69650B (de) * 1978-07-20 1982-07-07 Science Union & Cie
US4329353A (en) * 1980-10-22 1982-05-11 Janssen Pharmaceutica, N.V. 1-(4-Aryl-cyclohexyl)piperidine derivatives, method of use thereof and pharmaceutical compositions thereof
JPS58180481A (ja) 1982-04-15 1983-10-21 Kyowa Hakko Kogyo Co Ltd 新規なピペリジン誘導体
EP0974583B1 (de) 1995-09-13 2002-05-29 Kyowa Hakko Kogyo Co., Ltd. Phenylpiperidin-derivate
US6180649B1 (en) * 1996-04-19 2001-01-30 Nerosearch A/S 1-(4-piperidyl)-benzimidazoles having neurotrophic activity
ES2226129T3 (es) 1997-05-30 2005-03-16 Banyu Pharmaceutical Co., Ltd. Derivados de 2-0x0imidazol.
SI0921125T1 (en) 1997-12-05 2002-04-30 F. Hoffmann-La Roche Ag 1,3,8-Triazaspiro(4,5)decan-4-on derivatives
US6166209A (en) 1997-12-11 2000-12-26 Hoffmann-La Roche Inc. Piperidine derivatives
US6626939B1 (en) 1997-12-18 2003-09-30 Boston Scientific Scimed, Inc. Stent-graft with bioabsorbable structural support
AU1679099A (en) * 1998-01-19 1999-08-02 Pfizer Inc. 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists
NZ507760A (en) 1998-03-26 2002-10-25 Japan Tobacco Inc Amide derivatives and nociceptin antagonists
AU3809999A (en) 1998-05-18 1999-12-06 Novo Nordisk A/S Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes
ID29137A (id) * 1998-07-27 2001-08-02 Schering Corp Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1
US6262066B1 (en) * 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
AU1816901A (en) * 1999-12-06 2001-06-12 Euro-Celtique S.A. Benzimidazole compounds having nociceptin receptor affinity

Also Published As

Publication number Publication date
DE60022226D1 (de) 2005-09-29
EP1242085B1 (de) 2005-08-24
JP2007277257A (ja) 2007-10-25
WO2001039775A1 (en) 2001-06-07
US7456198B2 (en) 2008-11-25
EP1242085A1 (de) 2002-09-25
US20060264638A1 (en) 2006-11-23
EP1242085A4 (de) 2003-02-12
HK1049284A1 (en) 2003-05-09
US20020128288A1 (en) 2002-09-12
HK1049284B (en) 2006-02-24
AU1816901A (en) 2001-06-12
US7678809B2 (en) 2010-03-16
JP2003524634A (ja) 2003-08-19

Similar Documents

Publication Publication Date Title
ATE302770T1 (de) Benzimidazolverbindungen die nociceptinrezeptoraffinität haben
NO20013444D0 (no) Triazolforbindelser med dopamin-D3-reseptor-affinet
GB0225474D0 (en) Therapeutic agents
DE60332137D1 (en) Cyclohexyl-sulphone als gamma-sekretase-inhibitoren
SE9900100D0 (sv) New compounds
DE69907977D1 (de) Pyrrolobenzodiazepine
DE60112974D1 (en) Carbolinderivate
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
TR199801255T2 (xx) Vitronektin resept�r antagonistleri.
MY135477A (en) 2-(2,6-dichlorophenyl)-diarylimidazoles
DE60216233D1 (en) Carbolinderivate
ATE304530T1 (de) Substituierte 1,5-dihydropyrrol-2-on-derivate wirksam als nmda-rezeptor-antagonisten für die behandlung von schmerzzuständen
TR200102178T2 (tr) CRF reseptör antagonistleri ve bunlarla ilgili yöntemler.
EA200200742A1 (ru) 1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии
TR200201245T2 (tr) Kanser tedavisi için onkolitik kombinasyonlar.
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
DE60317675D1 (de) KRYSTALLINE 2,5-DIONE-3-(1-METHYL-1H-INDOL-3-YL)-4-i1-(PYRIDIN-2-YLMETHYL)PIPERIDIN-4-YL -1H-INDOL-3-YL -1H-PYRROLE MONO-HYDROCHLORIDE
DE60112960D1 (de) Kondensierte pyridoindolderivate
AR022321A1 (es) Derivados de anticonvulsivo utiles para el tratamiento de la migrana transformada
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
EP1572129A4 (de) Amidin-derivate zur behandlung von amyloidose
ATE232081T1 (de) Orale zusammensetzung enthaltend perlit
DE502004007387D1 (de) Triazolverbindungen und ihre therapeutische verwendung
DE60204882D1 (de) Zykloalkenylsulfonamidderivate
ZA200107985B (en) Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties